These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 16982553)

  • 21. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL; Horsman MR
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR; Nielsen T; Østergaard L; Overgaard J
    Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameters affecting the response of experimental tumours to fractionated radiotherapy.
    Beck-Bornholdt HP
    Strahlenther Onkol; 1988 Mar; 164(3):155-64. PubMed ID: 3281297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractionated thermochemotherapy in vivo of a C3H mouse mammary carcinoma.
    Monge OR; Rofstad EK
    Radiother Oncol; 1991 Jul; 21(3):171-8. PubMed ID: 1924852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A summary of the studies on x-agent.
    Moriyama H
    Yokohama Med Bull; 1966 Apr; 17(2):31-43. PubMed ID: 5326432
    [No Abstract]   [Full Text] [Related]  

  • 26.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 27.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.